Yang, T.-Y.; Kao, H.-Y.; Lu, P.-L.; Chen, P.-Y.; Wang, S.-C.; Wang, L.-C.; Hsieh, Y.-J.; Tseng, S.-P.
Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant Klebsiella pneumoniae. Pharmaceuticals 2021, 14, 795.
https://doi.org/10.3390/ph14080795
AMA Style
Yang T-Y, Kao H-Y, Lu P-L, Chen P-Y, Wang S-C, Wang L-C, Hsieh Y-J, Tseng S-P.
Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant Klebsiella pneumoniae. Pharmaceuticals. 2021; 14(8):795.
https://doi.org/10.3390/ph14080795
Chicago/Turabian Style
Yang, Tsung-Ying, Hao-Yun Kao, Po-Liang Lu, Pei-Yu Chen, Shu-Chi Wang, Liang-Chun Wang, Ya-Ju Hsieh, and Sung-Pin Tseng.
2021. "Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant Klebsiella pneumoniae" Pharmaceuticals 14, no. 8: 795.
https://doi.org/10.3390/ph14080795
APA Style
Yang, T.-Y., Kao, H.-Y., Lu, P.-L., Chen, P.-Y., Wang, S.-C., Wang, L.-C., Hsieh, Y.-J., & Tseng, S.-P.
(2021). Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant Klebsiella pneumoniae. Pharmaceuticals, 14(8), 795.
https://doi.org/10.3390/ph14080795